Capgemini announced on Monday that it had made a breakthrough in generative biology, also known as engineering or synthetic biology, at its deep tech powerhouse Cambridge Consultants. The news was been widely picked up, including by PharmaTimes
Capgemini’s new patent-pending generative AI uses specialized large language models to accelerate the bioeconomy and biotechnology sector by drastically reducing the time and resources needed for research and development.
What is deep tech? When discussing deep tech meaning, deep tech consultants Cambridge Consultants define it as a strategy for value and commercial advantage.
What is biological computing, and what role will it play when looking to the sustainable technology of the future?
Ophthalmology is undergoing significant transformation that will reshape eyecare in the 21st century. It has become imperative to innovate and optimise clinical workflows for greater efficiency.
![Quantum technology needs Deep [tech] Thinking](https://www.cambridgeconsultants.com/wp-content/uploads/2023/11/Summary_Quantum-technology-needs Deep-tech-Thinking _0.jpg?w=550&h=425&crop=1)
The time to start planning your roadmap to commercial quantum adoption is now. Where to start? Read our exclusive report.